A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT07569042 · RECRUITING
Trial details
- NCT number
- NCT07569042
- Sponsor
- Novelwise Pharmaceutical Corporation
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2029-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.